Clearmind Medicine Common Stock Today
| CMND Stock | USD 1.12 0.05 4.27% |
PerformanceVery Weak
| Odds Of DistressLow
|
Clearmind Medicine is trading at 1.12 as of the 23rd of March 2025, a 4.27 percent down since the beginning of the trading day. The stock's lowest day price was 1.1. Clearmind Medicine has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 16th of August 2021 | Category Healthcare | Classification Health Care |
Clearmind Medicine is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 5.13 M outstanding shares of which 274.61 K shares are currently shorted by private and institutional investors with about 3.19 trading days to cover. More on Clearmind Medicine Common
Moving against Clearmind Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Clearmind Stock Highlights
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, IT, Computers, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors) | |||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Clearmind Medicine can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Clearmind Medicine's financial leverage. It provides some insight into what part of Clearmind Medicine's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Clearmind Medicine Common (CMND) is traded on NASDAQ Exchange in USA. It is located in 1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5 and employs 7 people. Clearmind Medicine is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.75 M. Clearmind Medicine Common conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5.13 M outstanding shares of which 274.61 K shares are currently shorted by private and institutional investors with about 3.19 trading days to cover.
Clearmind Medicine Common currently holds about 1.65 K in cash with (4.86 M) of positive cash flow from operations.
Check Clearmind Medicine Probability Of Bankruptcy
Ownership AllocationAlmost 85.14 percent of Clearmind Medicine outstanding shares are held by general public with 2.93 (percent) owned by insiders and only 11.93 % by other corporate entities.
Check Clearmind Ownership Details
Clearmind Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Gotham Asset Management, Llc | 2024-12-31 | 342.9 K | |
| Advisorshares Investments, Llc | 2024-12-31 | 167.9 K | |
| Virtu Financial Llc | 2024-12-31 | 39.5 K | |
| Citadel Advisors Llc | 2024-12-31 | 38.2 K | |
| Cornerstone Wealth Group, Llc | 2024-12-31 | 20 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.6 K | |
| Tower Research Capital Llc | 2024-12-31 | 935 | |
| Royal Bank Of Canada | 2024-12-31 | 569 | |
| Geode Capital Management, Llc | 2024-09-30 | 0.0 | |
| Hrt Financial Llc | 2024-12-31 | 0.0 | |
| Ubs Group Ag | 2024-12-31 | 0.0 |
Clearmind Medicine Historical Income Statement
Clearmind Stock Against Markets
Clearmind Medicine Corporate Management
| BCom BComm | CFO Director | Profile | |
| Mylene Touboul | Accounting Manager | Profile | |
| Gilad Babchuk | Head Communication | Profile | |
| Adi Varon | Controller | Profile | |
| Pr Haden | Vice Development | Profile | |
| Pr MSW | Vice Development | Profile | |
| Adi ZuloffShani | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearmind Medicine Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.